Results 251 to 260 of about 321,844 (313)
Cost-of-Illness Analysis of Diabetic Foot Ulcer: A Prevalence-Based Approach in Southwest of Iran. [PDF]
Med J Islam Repub IranTahmasebi-Ghorrabi A +5 more
europepmc +1 more source
Cost-of-illness analysis of ulcerative colitis patients treated with biological therapy: a prospective observational study in Iran. [PDF]
BMC Health Serv ResKarami H +6 more
europepmc +1 more source
Dosing Biologic Drugs for Patients With Obesity: One Size Does Not Fit All
Arthritis &Rheumatology, EarlyView.
Stephen J. Balevic +2 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Pain & Palliative Care Pharmacotherapy, 2003
Cost-of-illness studies measure the overall economic impact of a disease on society. Such studies are important in setting public health priorities and for economic evaluation of new treatments. These studies should take the societal perspective and include both direct and indirect costs. Often indirect costs exceed direct costs.
openaire +2 more sources
Cost-of-illness studies measure the overall economic impact of a disease on society. Such studies are important in setting public health priorities and for economic evaluation of new treatments. These studies should take the societal perspective and include both direct and indirect costs. Often indirect costs exceed direct costs.
openaire +2 more sources
2020
Cost of illness (COI) or burden of illness (BOI) measures the economic burden of disease and illness on society. They can take either a prevalence- or incidence-based approach. COI or BOI lays the foundation on which the different types of analyses that are used to make decisions in allocation of healthcare resources are framed.
openaire +1 more source
Cost of illness (COI) or burden of illness (BOI) measures the economic burden of disease and illness on society. They can take either a prevalence- or incidence-based approach. COI or BOI lays the foundation on which the different types of analyses that are used to make decisions in allocation of healthcare resources are framed.
openaire +1 more source
Cost-of-Illness in Rare Diseases
2017Cost-of-illness (COI) studies quantify the economic burden of a disease, including direct healthcare and non-healthcare costs and productivity losses. Different approaches can be adopted to evaluate the resources associated to a disease and to calculate the total costs.
Renata, Linertová +2 more
openaire +2 more sources
PharmacoEconomics, 2011
Cost-of-illness (COI) studies aim to assess the economic burden of health problems on the population overall, and they are conducted for an ever widening range of health conditions and geographical settings. While they attract much interest from public health advocates and healthcare policy makers, inconsistencies in the way in which they are conducted
Larg, A., Moss, J.
openaire +3 more sources
Cost-of-illness (COI) studies aim to assess the economic burden of health problems on the population overall, and they are conducted for an ever widening range of health conditions and geographical settings. While they attract much interest from public health advocates and healthcare policy makers, inconsistencies in the way in which they are conducted
Larg, A., Moss, J.
openaire +3 more sources